Effect of Invasive Hemodynamic Monitoring on the Outcomes of Cardiogenic Shock in Patients With Acute Myocardial

Amin Daoulah1, Rishard Abdul2, Ahmed Elmahrouk1,3

  • 1Department of Cardiovascular Medicine, King Faisal Specialist Hospital & Research Center, Jeddah, Kingdom of Saudi Arabia.

Angiology
|March 2, 2026
PubMed

Insights

Invasive hemodynamic monitoring did not improve outcomes for patients with acute myocardial infarction and cardiogenic shock (AMI-CS). Mortality rates were similar between invasive and routine monitoring groups, highlighting the need for further research.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Clinical Hemodynamics

Background:

  • The benefit of invasive hemodynamic monitoring in acute myocardial infarction with cardiogenic shock (AMI-CS) remains debated.
  • Current guidelines lack definitive recommendations on optimal hemodynamic monitoring strategies for AMI-CS patients.

Purpose of the Study:

  • To investigate the impact of invasive hemodynamic monitoring on in-hospital mortality in patients with AMI-CS.
  • To compare outcomes between patients with AMI-CS who received invasive versus non-invasive hemodynamic monitoring.

Main Methods:

  • Analysis of 1513 patients with AMI-CS from 2020-2022, comparing outcomes based on invasive monitoring use.
  • Utilized propensity score matching to create comparable groups (488 pairs).
  • Assessed in-hospital mortality, mechanical support escalation, and hospital length of stay.

Main Results:

  • No significant difference in mortality was observed between invasive and routine monitoring groups (49.0% vs 49.18%, P > .99).
  • Patients with invasive monitoring had longer hospital stays (7 vs 6 days, P = .016) and were more likely to require advanced interventions.
  • Specific hemodynamic parameters (cardiac index, PAWCP, RAP) and Swan-Ganz catheter use did not predict mortality in the invasive monitoring group.

Conclusions:

  • Invasive hemodynamic monitoring is not associated with improved in-hospital mortality in AMI-CS patients compared to routine monitoring.
  • Findings underscore inconsistent evidence regarding hemodynamic monitoring methods in AMI-CS.
  • Further research is necessary to guide clinical decision-making for optimal patient management.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
349
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
404
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.8K
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
578